These elevated IL-22 levels during CHB and CHC infections could contribute to chronic inflammation and increased severity of liver fibrosis (120, 141, 195, 214), by enhancing the recruitment of proinflammatory Th17 cells into the liver and a persistent activation and proliferation of HSCs (120, 195). This evidence concerns the gene IL22 and Hepatic fibrosis.